Legacy Capital Group California, Inc. Dr Reddys Laboratories LTD Transaction History
Legacy Capital Group California, Inc.
- $328 Billion
- Q4 2024
A detailed history of Legacy Capital Group California, Inc. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 13,741 shares of RDY stock, worth $183,304. This represents 0.07% of its overall portfolio holdings.
Number of Shares
13,741
Previous 2,726
404.07%
Holding current value
$183,304
Previous $217 Million
0.18%
% of portfolio
0.07%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding RDY
# of Institutions
265Shares Held
107MCall Options Held
71KPut Options Held
22.5K-
Robeco Institutional Asset Management B.V.11.4MShares$153 Million0.35% of portfolio
-
Morgan Stanley New York, NY11.3MShares$150 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A610MShares$134 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.42MShares$126 Million0.23% of portfolio
-
Aikya Investment Management LTD London, X05.61MShares$74.8 Million36.88% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.21B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...